Massage therapy feasibility for gynecologic cancer patients during infusion
Official title: The Impact of Massage Therapy on Pain and Anxiety of Patients With Gynecologic Cancer While Receiving Infusion Treatment (IMPACT)
Run by University of Kentucky · NCT07502157 · Data updated 2026-11-12
This study tests whether it's feasible to run a massage therapy program for patients with gynecologic cancer who are receiving infusion treatments.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | Women only |
| Enrollment | 24 (estimated) |
| Sponsor | University of Kentucky Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Lexington, Kentucky) |
| Status | Recruiting |
| Started | September 3, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07502157 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with gynecologic cancer actively receiving infusion therapy at an academic medical center who are willing to participate in a massage intervention study.
✕Probably not a fit
Patients not experiencing significant pain or anxiety for whom massage would not be expected to provide measurable benefit during infusion sessions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial aims to determine if a massage intervention can be implemented in an infusion center at an academic hospital and whether pain and anxiety can be measured before and after the sessions. It uses a randomized-like design with an attention control to explore feasibility aspects, including recruitment, retention, assessor blinding, and resource needs. Outcomes focus on feasibility metrics and basic pain and anxiety measures during infusion visits. The study will help decide how to optimize design for a larger effectiveness trial and what massage modalities and locations are practical for this population.
Why it matters
Potential benefit: If feasible, massage therapy could become a practical option to reduce pain and anxiety for gynecologic cancer patients during infusion treatments.
How similar studies have gone: Previous research supports feasibility and patient-reported benefits of massage in cancer care, but this specific infusion-center feasibility study is one of the initial attempts in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with gynecologic cancer receiving active treatment of infusion, including but not limited to chemotherapy, immunotherapy, antibiotics, and blood. * Patients with gynecological cancer undergoing an infusion for the first time. Exclusion Criteria: * Patient with gynecologic cancer that has received infusion therapy anytime within the past 2 years.
Where it's running
-
University of Kentucky
Lexington, Kentucky, United States Recruiting
Study contacts
- Principal investigator: Jill S Cole, MA, LMT, BCTMB — University of Kentucky, Integrative Medicine and Health
- Study coordinator: Jill S Cole, MA, LMT, BCMTB
- Email: jill.cole1@uky.edu
- Phone: 859-323-7087
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NMTCuff vs standard TOF monitoring during gynecologic oncology surgery
This study tests whether NMTCuff monitoring can better detect neuromuscular recovery than standard TOF monitoring in women undergoing laparoscopic gynecologic cancer surgery.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Personalized supervised exercise program for adults with breast or gynecologic cancer
A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.
-
Cesium-131 brachytherapy to preserve organs in recurrent cervical or endometrial cancer
This study tests whether implanting small cesium-131 seeds can provide targeted radiation to vaginal recurrences of cervical or endometrial cancer in patients who previously had pelvic radiation, with the goal of preserving organs.
-
National registry of endometrial cancer cases in Italy
This project will collect clinical and molecular information from adults treated for endometrial cancer at participating Italian oncology centers to see if a national database can improve understanding of outcomes and care.
-
High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)
This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.